Bibliotecas PUC-SP - Busca Integrada

Deciphering the association between HIV-specific immunity and immune reconstitution

di Ole S. Søgaard
Pubblicato in EBioMedicine (2021-05-01)

Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues

di Paul W. Denton, Ole S. Søgaard, Ole S. Søgaard, Martin Tolstrup, Martin Tolstrup
Pubblicato in Frontiers in Microbiology (2019-08-01)

Development of single-cell transcriptomic atlas of human plasmacytoid dendritic cells from people with HIV-1

di Lamin B. Cham, Lin Lin, Martin Tolstrup, Ole S. Søgaard
Pubblicato in STAR Protocols (2024-03-01)

Immunomodulation with IL-7 and IL-15 in HIV-1 infection

di Jesper D. Gunst, Nilu Goonetilleke, Thomas A. Rasmussen, Ole S. Søgaard
Pubblicato in Journal of Virus Eradication (2023-09-01)

TLR9-adjuvanted pneumococcal conjugate vaccine induces antibody-independent memory responses in HIV-infected adults

di Rasmus Offersen, Jesper Melchjorsen, Søren R. Paludan, Lars Østergaard, Martin Tolstrup, Ole S. Søgaard
Pubblicato in Human Vaccines & Immunotherapeutics (2012-08-01)

Immune checkpoints and the HIV-1 reservoir: proceed with caution

di Rikke Olesen, Steffen Leth, Rasmus Nymann, Lars Østergaard, Ole S. Søgaard, Paul W. Denton, Martin Tolstrup
Pubblicato in Journal of Virus Eradication (2016-07-01)

Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis

di Sisse R. Ostrowski, Sisse R. Ostrowski, Ole S. Søgaard, Ole S. Søgaard, Martin Tolstrup, Martin Tolstrup, Nina B. Stærke, Nina B. Stærke, Jens Lundgren, Jens Lundgren, Lars Østergaard, Lars Østergaard, Anne-Mette Hvas, Anne-Mette Hvas
Pubblicato in Frontiers in Immunology (2021-11-01)

Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infection.

di Ole S Søgaard, Nicolai Lohse, Lars Østergaard, Gitte Kronborg, Birgit Røge, Jan Gerstoft, Henrik T Sørensen, Niels Obel
Pubblicato in PLoS ONE (2012-01-01)

The impact of B-cell perturbations on pneumococcal conjugate vaccine response in HIV-infected adults.

di Thomas G Johannesson, Ole S Søgaard, Martin Tolstrup, Mikkel S Petersen, Jens M Bernth-Jensen, Lars Østergaard, Christian Erikstrup
Pubblicato in PLoS ONE (2012-01-01)

Mortality after hospitalization for pneumonia among individuals with HIV, 1995-2008: a Danish cohort study.

di Ole S Søgaard, Nicolai Lohse, Jan Gerstoft, Gitte Kronborg, Lars Østergaard, Court Pedersen, Gitte Pedersen, Henrik Toft Sørensen, Niels Obel
Pubblicato in PLoS ONE (2009-01-01)

Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection

di Maria Zurek Munk-Madsen, Lars Toft, Tina Kube, Rolf Richter, Lars Ostergaard, Ole S. Søgaard, Martin Tolstrup, Andreas M. Kaufmann
Pubblicato in Human Vaccines & Immunotherapeutics (2018-04-01)

Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency ex vivo without T cell activation

di Jesper D. Gunst, Kathrine Kjær, Rikke Olesen, Thomas A. Rasmussen, Lars Østergaard, Paul W. Denton, Ole S. Søgaard, Martin Tolstrup
Pubblicato in Journal of Virus Eradication (2019-07-01)

Effect of Age on Innate and Adaptive Immunity in Hospitalized COVID-19 Patients

di Lamin B. Cham, Marie Høst Pahus, Kristoffer Grønhøj, Rikke Olesen, Hien Ngo, Ida Monrad, Mads Kjolby, Martin Tolstrup, Jesper Damsgaard Gunst, Ole S. Søgaard
Pubblicato in Journal of Clinical Medicine (2021-10-01)

Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients.

di Anni A Winckelmann, Lærke V Munk-Petersen, Thomas A Rasmussen, Jesper Melchjorsen, Thomas J Hjelholt, David Montefiori, Lars Østergaard, Ole S Søgaard, Martin Tolstrup
Pubblicato in PLoS ONE (2013-01-01)

Redirector of Vaccine-induced Effector Responses (RoVER) for specific killing of cellular targetsResearch in context

di Christina V. Konrad, Emma F. Iversen, Jesper D. Gunst, Ida Monrad, Andreas Holleufer, Rune Hartmann, Lars J. Østergaard, Ole S. Søgaard, Mariane H. Schleimann, Martin Tolstrup
Pubblicato in EBioMedicine (2023-10-01)

Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5-8 Days.

di Mykola Pinkevych, Stephen J Kent, Martin Tolstrup, Sharon R Lewin, David A Cooper, Ole S Søgaard, Thomas A Rasmussen, Anthony D Kelleher, Deborah Cromer, Miles P Davenport
Pubblicato in PLoS Pathogens (2016-08-01)

HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission.

di Mykola Pinkevych, Deborah Cromer, Martin Tolstrup, Andrew J Grimm, David A Cooper, Sharon R Lewin, Ole S Søgaard, Thomas A Rasmussen, Stephen J Kent, Anthony D Kelleher, Miles P Davenport
Pubblicato in PLoS Pathogens (2015-07-01)

Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission.

di Mykola Pinkevych, Deborah Cromer, Martin Tolstrup, Andrew J Grimm, David A Cooper, Sharon R Lewin, Ole S Søgaard, Thomas A Rasmussen, Stephen J Kent, Anthony D Kelleher, Miles P Davenport
Pubblicato in PLoS Pathogens (2016-08-01)

Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients

di Ane Bjerg Christensen, Anders Dige, Johan Vad-Nielsen, Christel R. Brinkmann, Mia Bendix, Lars Østergaard, Martin Tolstrup, Ole S. Søgaard, Thomas A. Rasmussen, Jens Randel Nyengaard, Jørgen Agnholt, Paul W. Denton
Pubblicato in Mediators of Inflammation (2015-01-01)

Single cell analysis reveals a subset of cytotoxic-like plasmacytoid dendritic cells in people with HIV-1

di Lamin B. Cham, Jesper D. Gunst, Mariane H. Schleimann, Giacomo S. Frattari, Miriam Rosas-Umbert, Line K. Vibholm, Renée M. van der Sluis, Martin R. Jakobsen, Rikke Olesen, Lin Lin, Martin Tolstrup, Ole S. Søgaard
Pubblicato in iScience (2023-09-01)